Simplifying care for rare brain tumors with AI
Part of Brain & nervous system, Cancer clinical trials.
This study uses artificial intelligence to improve care for adults with rare brain tumors who are scheduled for surgery. It aims to make treatment pathways simpler and better tailored to each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a rare brain tumor (fewer than 6 cases per 100,000 people each year)
- You are scheduled for a craniotomy (surgery through the skull) to remove the tumor
- You speak Italian as your first language
- You have access to a Windows PC or laptop with internet at home
- You do not have a serious mental health condition or take psychiatric medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether artificial intelligence can reduce workload when preparing rare tumor case reports. It seeks doctors, medical students, or postdoctoral students to participate.
This trial tests if a smartphone app can help patients or caregivers perform a neurological exam at home. It aims to make check-ups easier for people with brain tumors.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
This trial uses artificial intelligence to improve ultrasound images taken during brain tumor surgery. It aims to help surgeons see the tumor more clearly and remove it more safely.
This trial uses artificial intelligence to analyze MRI scans and help doctors identify the type of brain tumor in children. It aims to improve treatment planning by providing a non-invasive way to predict the tumor subtype before surgery.
This study tests a remote program to help with memory and thinking problems caused by a grade 2 or 3 brain tumor. It is for people who have had surgery and are at least 6 months past any radiation or chemotherapy.
Hear when a new Brain Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.